Clinical Trial Update: DNA Microarray Study of Pancreas Cancer

View source ↗

Summary

The clinical trial NCT00680420, a DNA microarray study in pancreatic cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Oregon Health and Science University | Conditions: Pancreas Cancer | Status: COMPLETED